建科院(300675.SZ):建科投資減持期屆滿 共減持157.13萬股
格隆匯11月7日丨建科院(300675.SZ)公佈,近日,公司收到建科投資《關於減持深圳市建築科學研究院股份有限公司股份計劃期限屆滿暨實施情況的告知函》,截至2019年11月7日,上述減持計劃期限屆滿,建科投資以集中競價方式共減持公司股份數量為157.13萬股(佔公司總股本的1.07%)。通過建科投資間接持有公司股票的102位股東(全部股東人數114人)參與此次減持計劃,公司董事長葉青未參與此次減持計劃。
此次減持後,建科投資持股比例由11.25%降至10.18%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.